Latest news
Genfleet becomes first to test oral KRAS G12D inhibitor in Phase III for NSCLC - AllSciAllSci · Mon, 10 Aug 2026 10:33:20 GMTSino Bio's benmelstobart-anlotinib regimen adds new China indication in first-line squamous NSCLC - AllSciAllSci · Fri, 07 Aug 2026 16:21:02 GMTMerck advances sac-TMT into first-line lung cancer redesign after endometrial Phase III win - AllSciAllSci · Wed, 05 Aug 2026 09:44:57 GMT